Pharmather, Inc.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Public, Subsidiary
- Established
- 2020-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.pharmather.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
Phase 2
Suspended
- Conditions
- Movement DisordersDyskinesiasCentral Nervous System DiseasesNervous System DiseasesNeurologic Manifestations
- Interventions
- First Posted Date
- 2021-06-03
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- PharmaTher Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04912115
- Locations
- 🇺🇸
Investigative Site #7, Tucson, Arizona, United States
🇺🇸Investigative Site #2, Chula Vista, California, United States
🇺🇸Investigative Site #1, Fountain Valley, California, United States
News
No news found